Desmond Padhi, Pharm.D. is an Operating Partner at Westlake BioPartners working broadly with the firm and portfolio companies to conceive, discover, and advance medicines into the clinic in all therapeutic areas and modalities. In this role he has served as founding CEO of Capsida Biotherapeutics and as interim CEO of Latigo Biotherapeutics, among others.
Prior to joining Westlake BioPartners, Desmond spent 20 years at Amgen, rising to Vice President of Translational Medicine and most recently Vice President of Pharmacokinetics and Drug Metabolism and Clinical Pharmacology. He has authored five patents and 45 publications in top-tier journals. Previously Desmond worked at the Schering-Plough Research Institute where he was the team leader for early development clinical programs. Desmond received his Doctor of Pharmacy degree from Wayne State University and completed his clinical pharmacology fellowship at Henry Ford Hospital. He received a B.S. in Biology and Bachelor of Pharmacy degree from the University of Saskatchewan.